Botanix Pharmaceuticals Ltd (BOT) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.591x

Based on the latest financial reports, Botanix Pharmaceuticals Ltd (BOT) has a cash flow conversion efficiency ratio of -0.591x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-48.02 Million ≈ $-33.98 Million USD) by net assets (AU$81.30 Million ≈ $57.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Botanix Pharmaceuticals Ltd for the company's overall valuation and market capitalisation.

Botanix Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Botanix Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Botanix Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Botanix Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Explore Botanix Pharmaceuticals Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Sangshin Electronics Co. Ltd
KQ:263810
-0.063x
Acarix A/S
ST:ACARIX
-0.270x
Jian Sin Industrial Co Ltd
TWO:4502
0.016x
Maskapai Reasuransi Indonesia
JK:MREI
0.031x
Porn Prom Metal Public Company Limited
BK:PPM
0.008x
Korea Eng Cons
KO:023350
-0.096x
Namibia Critical Metals Inc
V:NMI
0.003x
Petratherm Ltd
AU:PTR
-0.044x

Annual Cash Flow Conversion Efficiency for Botanix Pharmaceuticals Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Botanix Pharmaceuticals Ltd from 1991 to 2025. View BOT stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$81.30 Million
≈ $57.52 Million
AU$-78.58 Million
≈ $-55.60 Million
-0.967x -1193.21%
2024-06-30 AU$108.73 Million
≈ $76.94 Million
AU$-8.13 Million
≈ $-5.75 Million
-0.075x +85.79%
2023-06-30 AU$22.95 Million
≈ $16.24 Million
AU$-12.07 Million
≈ $-8.54 Million
-0.526x +61.66%
2022-06-30 AU$8.15 Million
≈ $5.77 Million
AU$-11.18 Million
≈ $-7.91 Million
-1.372x -861.49%
2021-06-30 AU$20.80 Million
≈ $14.72 Million
AU$-2.97 Million
≈ $-2.10 Million
-0.143x +80.57%
2020-06-30 AU$23.64 Million
≈ $16.72 Million
AU$-17.36 Million
≈ $-12.28 Million
-0.734x +96.56%
2019-06-30 AU$615.22K
≈ $435.30K
AU$-13.14 Million
≈ $-9.30 Million
-21.360x -3410.32%
2018-06-30 AU$16.28 Million
≈ $11.52 Million
AU$-9.91 Million
≈ $-7.01 Million
-0.608x +28.70%
2017-06-30 AU$5.44 Million
≈ $3.85 Million
AU$-4.64 Million
≈ $-3.28 Million
-0.853x -40490.24%
2016-06-30 AU$3.18 Million
≈ $2.25 Million
AU$-6.69K
≈ $-4.73K
-0.002x +99.79%
2015-06-30 AU$1.23 Million
≈ $869.58K
AU$-1.20 Million
≈ $-851.81K
-0.980x -70.31%
2014-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-1.29 Million
≈ $-913.02K
-0.575x -238.34%
2013-06-30 AU$-2.50 Million
≈ $-1.77 Million
AU$-1.04 Million
≈ $-735.77K
0.416x -13.19%
2012-06-30 AU$-2.33 Million
≈ $-1.65 Million
AU$-1.12 Million
≈ $-790.81K
0.479x +54.21%
2011-06-30 AU$-2.23 Million
≈ $-1.58 Million
AU$-692.97K
≈ $-490.32K
0.311x -35.20%
2010-06-30 AU$-1.80 Million
≈ $-1.27 Million
AU$-861.12K
≈ $-609.30K
0.479x +125.99%
2009-06-30 AU$877.74K
≈ $621.06K
AU$-1.62 Million
≈ $-1.15 Million
-1.844x +0.15%
2008-06-30 AU$1.29 Million
≈ $909.99K
AU$-2.38 Million
≈ $-1.68 Million
-1.847x -94.45%
2007-06-30 AU$2.90 Million
≈ $2.05 Million
AU$-2.75 Million
≈ $-1.95 Million
-0.950x +29.94%
2006-06-30 AU$2.22 Million
≈ $1.57 Million
AU$-3.01 Million
≈ $-2.13 Million
-1.356x -64.76%
2005-06-30 AU$3.46 Million
≈ $2.45 Million
AU$-2.84 Million
≈ $-2.01 Million
-0.823x -213.18%
2004-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-589.68K
≈ $-417.24K
-0.263x +9.32%
2002-06-30 AU$4.05 Million
≈ $2.86 Million
AU$-1.17 Million
≈ $-829.68K
-0.290x -395.90%
2001-06-30 AU$5.69 Million
≈ $4.03 Million
AU$-332.70K
≈ $-235.40K
-0.058x +80.44%
2000-06-30 AU$5.15 Million
≈ $3.64 Million
AU$-1.54 Million
≈ $-1.09 Million
-0.299x +45.25%
1999-06-30 AU$8.08 Million
≈ $5.72 Million
AU$-4.41 Million
≈ $-3.12 Million
-0.546x -218.85%
1998-06-30 AU$15.75 Million
≈ $11.15 Million
AU$7.23 Million
≈ $5.12 Million
0.459x +547.35%
1997-06-30 AU$32.05 Million
≈ $22.67 Million
AU$-3.29 Million
≈ $-2.33 Million
-0.103x -8556.45%
1996-06-30 AU$37.91 Million
≈ $26.83 Million
AU$46.00K
≈ $32.55K
0.001x -99.25%
1995-06-30 AU$38.44 Million
≈ $27.20 Million
AU$6.24 Million
≈ $4.42 Million
0.162x +68.58%
1994-06-30 AU$26.04 Million
≈ $18.43 Million
AU$2.51 Million
≈ $1.78 Million
0.096x +25.35%
1993-06-30 AU$18.35 Million
≈ $12.98 Million
AU$1.41 Million
≈ $997.66K
0.077x -39.42%
1992-06-30 AU$11.41 Million
≈ $8.07 Million
AU$1.45 Million
≈ $1.02 Million
0.127x -15.46%
1991-06-30 AU$12.88 Million
≈ $9.11 Million
AU$1.93 Million
≈ $1.37 Million
0.150x --

About Botanix Pharmaceuticals Ltd

AU:BOT Australia Biotechnology
Market Cap
$27.89 Million
AU$39.41 Million AUD
Market Cap Rank
#24128 Global
#953 in Australia
Share Price
AU$0.02
Change (1 day)
+11.11%
52-Week Range
AU$0.02 - AU$0.17
All Time High
AU$0.52
About

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment o… Read more